CORE E: Abstract Despite an enormous increase in the basic science understanding of many IDDs, progress in the application of this basic knowledge in the clinic has been limited. The reasons for this gap in ?translation? are many, but most agree that advances in defining, dissecting, and understanding the multiple dimensions of IDD phenotypes have lagged, with a few exceptions. A few examples are illustrative. Social functioning, an obvious and foundational element of adaptive ability and quality of life, is a natural target for intervention efforts across all IDDs, yet the field lacks suitable measurement tools that are well suited for application in clinical trials, and few measures have been rigorously compared to real world functioning for their precision and validity. Social measures often applied for diagnosis (Vineland Socialization or Communication subscales, ADOS, Social Responsiveness Scale-2, Aberrant Behavior Checklist-Social Withdrawal subscale [ABC-SW]) are either insensitive to change (too few items and limited range of scoring), too broad, too burdensome for repeated short-term use, too narrow, and/or vulnerable to expectancy bias. Even though the ABC-SW subscale has received a partial endorsement as a possible endpoint for capturing treatment effects on social behavior in Autism Spectrum Disorder (ASD)(and a separate modification likewise proposed for Fragile X Syndrome [FXS] trials), a review of its performance finds it vulnerable to placebo effects. Moreover, on closer inspection, the majority of the subscale's items are restricted to social interest alone, not capturing the many other possible social dimensions of interest. An objective of our Core is to continue our existing efforts to creatively increase study impact by developing and applying novel measurement approaches. An example was the substudy of McCracken and Kasari embedded in the NIMH Research Units on Pediatric Pharmacology (RUPP) Autism Network's Methylphenidate for the Treatment of Hyperactivity in Pervasive Developmental Disorder randomized clinical trial (RUPP Autism Network, 2005). Using an abbreviated (<10- minute scripted interaction repeated weekly) modification of the Early Social Communication Scales (ESCS), we documented the first example in the literature to our knowledge of a positive drug effect on core deficits of joint attention and emotion regulation in ASD.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD087101-04
Application #
9597547
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
Budget Start
2018-11-01
Budget End
2019-10-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lee, Frank Y; Wang, Huei-Bin; Hitchcock, Olivia N et al. (2018) Sleep/Wake Disruption in a Mouse Model of BLOC-1 Deficiency. Front Neurosci 12:759
Somerville, Leah H; Bookheimer, Susan Y; Buckner, Randy L et al. (2018) The Lifespan Human Connectome Project in Development: A large-scale study of brain connectivity development in 5-21 year olds. Neuroimage 183:456-468
Green, Shulamite A; Hernandez, Leanna M; Bowman, Hilary C et al. (2018) Sensory over-responsivity and social cognition in ASD: Effects of aversive sensory stimuli and attentional modulation on neural responses to social cues. Dev Cogn Neurosci 29:127-139
Clark, Duncan B; Fisher, Celia B; Bookheimer, Susan et al. (2018) Biomedical ethics and clinical oversight in multisite observational neuroimaging studies with children and adolescents: The ABCD experience. Dev Cogn Neurosci 32:143-154
Dickinson, Abigail; DiStefano, Charlotte; Lin, Yin-Ying et al. (2018) Interhemispheric alpha-band hypoconnectivity in children with autism spectrum disorder. Behav Brain Res 348:227-234
Nachun, Daniel; Gao, Fuying; Isaacs, Charles et al. (2018) Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich's ataxia patients. Hum Mol Genet 27:2965-2977
Meyer, Jochen F; Golshani, Peyman; Smirnakis, Stelios M (2018) The Effect of Single Pyramidal Neuron Firing Within Layer 2/3 and Layer 4 in Mouse V1. Front Neural Circuits 12:29
Dickinson, Abigail; DiStefano, Charlotte; Senturk, Damla et al. (2018) Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur J Neurosci 47:643-651
Rao, Jia-Sheng; Zhao, Can; Zhang, Aifeng et al. (2018) NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury. Proc Natl Acad Sci U S A 115:E5595-E5604
Douglas, P K; Gutman, Boris; Anderson, Ariana et al. (2018) Hemispheric brain asymmetry differences in youths with attention-deficit/hyperactivity disorder. Neuroimage Clin 18:744-752

Showing the most recent 10 out of 40 publications